The institutional investor held 308,004 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $18.87M, down from 314,600 at the end of the previous reported quarter. The firm had revenue of $5.24 billion for the quarter, compared to analyst estimates of $5.14 billion. Shares are trading price at $52.30 with move of -0.15%.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. BMY underperformed by 0.18% the S&P500.
Johnson Investment Counsel Inc decreased its stake in Sap Se (SAP) by 11.55% based on its latest 2017Q4 regulatory filing with the SEC.
Bruni J V & Company, which manages about $542.07 million and $592.37 million US Long portfolio, decreased its stake in Taiwan Semiconductor Mfg Ltd (NYSE:TSM) by 64,661 shares to 848,961 shares, valued at $33.66 million in 2017Q4, according to the filing. Jefferies Group restated a "hold" rating and set a $66.00 price objective on shares of Bristol-Myers Squibb in a research report on Friday, April 13th. The company had Year Ago Sales of 4.93 Billion. The stock decreased 0.13% or $0.04 during the last trading session, reaching $31.58. About 631,126 shares traded. It has underperformed by 65.90% the S&P500.
Analysts await Blucora, Inc. During the same period in the prior year, the company earned $0.63 EPS. analysts forecast that Bristol-Myers Squibb will post 3.22 earnings per share for the current year. Penn Management holds 0.12% or 223,668 shares in its portfolio. Cypress Capital Mngmt Limited Liability Corporation reported 6,450 shs.
Ameriprise Financial Inc, which manages about $219.26 billion US Long portfolio, upped its stake in Idacorp Inc (NYSE:IDA) by 9,514 shares to 165,669 shares, valued at $15.13 million in 2017Q4, according to the filing. It also reduced its holding in Thermo Fisher Scientific Inc (NYSE:TMO) by 144,800 shares in the quarter, leaving it with 389,400 shares, and cut its stake in Array Biopharma Inc (NASDAQ:ARRY). (NASDAQ:PTEN) earned "Buy" rating by Citigroup on Thursday, October 5. Therefore 36% are positive. Since October 19, 2017 according to StockzIntelligence Inc Bristol Myers has 19 analyst reports. The company was maintained on Wednesday, April 5 by BMO Capital Markets. On Thursday, October 12 the stock rating was downgraded by Cowen & Co to "Hold". The firm has "Underperform" rating given on Monday, June 13 by Jefferies. The stock has "Sell" rating by BMO Capital Markets on Wednesday, August 16. The company was maintained on Tuesday, February 6 by Leerink Swann. On Monday, January 8 the stock rating was maintained by SunTrust with "Buy". The rating was maintained by Keefe Bruyette & Woods with "Buy" on Wednesday, June 14. Veritable Ltd Partnership holds 0.01% of its portfolio in American Airlines Group Inc. Hancock Holdings has 21,624 shares. Three investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have issued a buy rating to the company's stock. Therefore 32% are positive. (NASDAQ:AAL) on Friday, October 21 with "Outperform" rating. Finally, Zacks Investment Research raised Bristol-Myers Squibb from a "sell" rating to a "hold" rating in a research report on Friday, January 19th. Whittier Tru Com stated it has 0.38% in Bristol-Myers Squibb Company (NYSE:BMY). Jefferies has "Hold" rating and $59 target.
Analysts Showing Optimistic Trends For T-Mobile US, Inc. (TMUS)
Also, insider Thomas Christopher Keys sold 25,000 shares of T-Mobile US stock in a transaction that occurred on Friday, March 9th. Finally, Meitav Dash Investments Ltd. purchased a new stake in shares of T-Mobile US during the 4th quarter worth about $644,000.
Robert De Niro opens Tribeca with rips of Trump: 'Lowlife-in-chief'
Festival organizers said this year's Tribeca has been programmed with some of De Niro's fighting spirit. Some elements of this year's Tribeca, which runs through April 29, are pointedly political.
NetApp (NTAP) Price Target Increased to $76.00 by Analysts at Argus
The data storage provider reported $0.99 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.91 by $0.08. With these types of results to display analysts, are more optimistic than before, leading 19 of analysts who cover VMware, Inc.
Investors sentiment decreased to 0.93 in 2017 Q4. The firm has "Equal-Weight" rating by Morgan Stanley given on Tuesday, April 17. The firm has "Buy" rating by UBS given on Friday, April 29. Leerink Swann maintained the stock with "Buy" rating in Wednesday, August 5 report. Pinnacle Wealth Management Advisory Group Ltd Liability Corporation holds 0.81% in Bristol-Myers Squibb Company (NYSE:BMY) or 23,833 shares. Carroll Assocs holds 0.13% or 19,047 shares. BMY's profit will be $1.37B for 15.62 P/E if the $0.84 EPS becomes a reality.
BMY had 1 insider sale and 1 insider buy since December 12, 2017. Presently, it has a Return on Equity (ROE) of 7.20% and Return on Investment (ROI) of 20.20%.
Weekly, Monthly, Quarterly And Six-Month Performance: Taking a look at the performance of FDC stock, an investor will come to know that the weekly performance for this stock valued at 0.46%, resulting in a performance for the month at -7.76%. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.55 and a quick ratio of 1.43. The ratio worsened due to BMY positioning: 72 sold and 526 reduced.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Outstanding shares refer to a company's stock now held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders. Cetera Advisor Netwr Limited Liability Corp invested in 60,343 shs. Shell Asset Mngmt reported 0.25% stake. Pitcairn, a Pennsylvania-based fund reported 16,340 shs. Fulton Bank Na accumulated 0.1% or 22,729 shs.
While looking at the Stock's Performance, Bristol-Myers Squibb Company now shows a Weekly Performance of -13.09%, where Monthly Performance is -20.84%, Quarterly performance is -15.44%, 6 Months performance is -17.83% and yearly performance percentage is -1.19%. Walleye Trading Ltd Liability Corp holds 0.04% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 131,776 shares.
Bristol-Myers Squibb Company (BMY) stock price distance from twenty day simple moving average slumped at -14.75% while its distance from fifty day simple moving average declined -18.34% along with -15.07% below distance from two hundred simple moving averages. The FCF Score of Bristol-Myers Squibb Company is 2.115778.
Recommended News
-
19 April 2018Pier 1 Imports, Inc. (PIR) stock dipped -13.72% Quarterly performance
Total volume is the number of shares or deals that point towards the overall activity of a security or market for a given period. On Friday, James noted Pier 1 had brought in a consultant for several months to assess the company's strengths and weaknesses.Montag A & Associates INC Decreased Its Suntrust Bks INC (STI) Stake
The company has a market cap of $31,586.85, a P/E ratio of 16.19, a price-to-earnings-growth ratio of 1.02 and a beta of 1.33. BMO Capital Markets maintained SunTrust Banks, Inc. (NYSE:STI) earned "Hold" rating by Sandler O'Neill on Monday, October 23.
19 April 2018California sends troops to Mexico border to fight crime, not immigration
Governors control the Guard troops in their states, but they are funded by the federal government. She said they were performing aerial surveillance and vehicle repairs. -
On May, 7 Boardwalk Pipeline Partners, LP (BWP) EPS Estimated At $0.40
The pipeline company reported $0.33 earnings per share for the quarter, missing analysts' consensus estimates of $0.40 by ($0.07). Pershing Gold Corporation engages in the exploration, development, and mining of gold and precious metals primarily in Nevada.Brokerages Set Rayonier Advanced Materials Inc (RYAM) Target Price at $20.75
Evanston Investments Inc Dba Evanston Advisors sold 5,941 shares as the company's stock rose 1.25% while stock markets declined. QS Investors LLC owned 0.34% of Rayonier Advanced Materials worth $2,991,000 at the end of the most recent quarter.Sarepta Therapeutics, Inc. (SRPT) stock returned 32.35% positive in past quarter
Therefore 100% are positive. 24 are the (NASDAQ:SRPT)'s ratings reports on April 19, 2018 according to StockzIntelligence Inc. LLC raised its stake in Sarepta Therapeutics by 63.4% in the fourth quarter. (NASDAQ:SRPT) rating on Wednesday, August 26. -
19 April 2018LeBron James scores 46 as Cleveland Cavaliers beat Indiana Pacers
Right out the gate, LeBron's first 16 points were the only points scored by the Cavaliers as they jumped out to an early lead. James' 24 points in Cleveland's 98-80 Game 1 loss were almost as many as the total of the other four starters combined (25).
19 April 2018Humboldt Broncos tribute concert scheduled for April 27 in Saskatoon
A GoFundMe page dedicated to the hockey team has raised more than $13 million in the 10 days since it launched. Joseph, Hunter, Wack and Tobin were all from the Edmonton-area: Joseph, Hunter, and Wack were from St.Phillips 66 (PSX) Gains Hold Rating from Royal Bank of Canada
Clarivest Asset Management Limited Liability invested in 0% or 7 shares. ( NYSE:CTL ), 7 have Buy rating, 1 Sell and 15 Hold. Its up 1.04, from 0.95 in 2017Q3. 204.38 million shares or 1.21% less from 206.89 million shares in 2017Q3 were reported. -
Liberty Global (LBTYA) Receives Average Recommendation of "Hold" from Analysts
The stock price is moving from its 200 days moving average with 1.4 percent and from 50 days moving average with 1.17 percent. The company also weighed on the Dow Jones Industrial Average, where it is the ninth heaviest-weighted member on the index.
19 April 2018TCS Q4 net profit rises 4.5%, beats estimates
The company had reported a net profit of Rs 6,608 crore in the same period last fiscal, TCS said in a regulatory filing. Board approved bonus of 1 share for every share held, and a final dividend of Rs 29/share.Glenn S. Boehnlein Sells 750 Shares of Stryker Co. (SYK) Stock
The medical technology company reported $1.96 EPS for the quarter, topping analysts' consensus estimates of $1.95 by $0.01. The stock of Stryker Corporation (NYSE:SYK) has "Underperform" rating given on Monday, December 14 by BMO Capital Markets.
